Literature DB >> 26650249

Long-term Erythrocytapheresis Is Associated With Reduced Liver Iron Concentration in Sickle Cell Disease.

Scott N Myers1, Ryan Eid, John Myers, Salvatore Bertolone, Arun Panigrahi, Jennifer Mullinax, Ashok B Raj.   

Abstract

BACKGROUND: Erythrocytapheresis procedures are increasingly used in sickle cell disease. Serum ferritin and noninvasive magnetic resonance imaging measurements of liver iron concentration (LIC) are frequently used to monitor iron overload secondary to hypertransfusion. There is a paucity of data describing the impact of long-term erythrocytapheresis (LTE) on LIC.
MATERIALS AND METHODS: We measured magnetic resonance imaging liver and cardiac iron on LTE subjects and stratified them into 2 groups: higher LIC (>3 mg/g) and lower LIC (<3 mg/g). χ(2) and t test were used to test for differences between the 2 groups. Logistic regression and generalized linear mixed-effects models were used to test what impacted LIC.
RESULTS: None of 29 sickle cell disease subjects maintained on LTE had high cardiac iron concentration. LIC was associated with serum ferritin (r=0.697, P<0.001) but was not associated with the total number of LTE procedures (r=-0.088, P=0.656) or total number of simple transfusions (r=0.316, P=0.108). The total number of LTE procedures was not associated with serum ferritin (r=0.040, P=0.838), the total number of simple transfusions (r=-0.258, P=0.184), or LIC group (r=-0.111, P=0.566).
CONCLUSION: There was no significant correlation between duration of LTE maintenance and LIC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26650249     DOI: 10.1097/MPH.0000000000000461

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  1 in total

1.  Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease.

Authors:  Ashok Raj; Kerry McGowan; Esther Knapp; Jun Zhao; Siddharth Shah
Journal:  Cureus       Date:  2022-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.